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Does anti-malarial drug knowledge predict
anti-malarial dispensing practice in drug outlets?
A survey of medicine retailers in western Kenya
Andria Rusk1*, Nathan Smith1, Diana Menya3,4, Andrew Obala2,3, Chrispinus Simiyu2,3, Barasa Khwa-Otsyula2,3
and Wendy O’Meara1,3,4,5
Abstract
Background: Malaria is a major cause of morbidity and mortality in Kenya, where it is the fifth leading cause of
death in both children and adults. Effectively managing malaria is dependent upon appropriate treatment. In Kenya,
between 17 to 83 percent of febrile individuals first seek treatment for febrile illness over the counter from
medicine retailers. Understanding medicine retailer knowledge and behaviour in treating suspected malaria and
dispensing anti-malarials is crucial.
Methods: To investigate medicine retailer knowledge about anti-malarials and their dispensing practices, a survey
was conducted of all retail drug outlets that sell anti-malarial medications and serve residents of the Webuye Health
and Demographic Surveillance Site in the Bungoma East District of western Kenya.
Results: Most of the medicine retailers surveyed (65%) were able to identify artemether-lumefantrine (AL) as the
Kenyan Ministry of Health recommended first-line anti-malarial therapy for uncomplicated malaria. Retailers who
correctly identified this treatment were also more likely to recommend AL to adult and paediatric customers.
However, the proportion of medicine retailers who recommend the correct treatment is disappointingly low.
Only 48% would recommend AL to adults, and 37% would recommend it to children. It was discovered that
customer demand has an influence on retailer behaviour. Retailer training and education were found to be
correlated with anti-malarial drug knowledge, which in turn is correlated with dispensing practices. Medicine retailer
behaviour, including patient referral practice and dispensing practices, are also correlated with knowledge of the
first-line anti-malarial medication. The Kenya Ministry of Health guidelines were found to influence retailer drug
stocking and dispensing behaviours.
Conclusion: Most medicine retailers could identify the recommended first-line treatment for uncomplicated
malaria, but the percentage that could not is still too high. Furthermore, knowing the MOH recommended
anti-malarial medication does not always ensure it is recommended or dispensed to customers. Retailer training
and education are both areas that could be improved. Considering the influence that patient demand has on
retailer behaviour, future interventions focusing on community education may positively influence appropriate
dispensing of anti-malarials.
Keywords: AMFm, Antimalarial, Retail shops, Medicine outlets, Training
* Correspondence: Andria.Rusk@alumni.duke.edu
1Duke Global Health Institute, Trent Hall, Durham, North Carolina, USA
Full list of author information is available at the end of the article
© 2012 Rusk et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Rusk et al. Malaria Journal 2012, 11:263
http://www.malariajournal.com/content/11/1/263
Background
Malaria is a major cause of morbidity and mortality, with
infection by Plasmodium falciparum responsible for ap-
proximately 515 million clinical infections annually [1].
An estimated 0.5 to 2.5 million deaths result from these
infections, with over 90% of these borne by Africa alone
[2]. In Kenya, it is the fifth leading cause of death in
both children and adults [3].
In response to the high levels of parasite resistance to
sulphadoxine-pyrimethamine (SP), the KenyanMinistry of
Health changed its first-line anti-malarial policy for treat-
ing uncomplicated malaria to artemether-lumefantrine,
an artemisinin-based combination therapy (ACT), in
2006. With this new treatment recommendation in place,
it became vital that development of drug resistance to
this new therapy was delayed as long as possible, and
that anti-malarial drug providers adhered to the new
recommendation, discontinued the use and prescrip-
tion of ineffective treatments, and that access to ACT
was broadened to reach as many infected individuals as
possible.
In sub-Saharan Africa, studies have shown that most
families first seek treatment for mild febrile illnesses in
the retail sector rather than through public health ser-
vices [4,5]. Particularly in populations with inadequate
access to health services, self-medicating with drugs pur-
chased at retail locations is a common practice [6-9]. To
increase access to ACT, efforts are being invested in
interventions targeting retail drug locations.
In August of 2010, Kenya was one of six countries to
launch Affordable Medicines Facility-malaria (AMFm), a
global subsidy program aimed at reducing the price of,
and improving access to, ACT. One goal of AMFm is to
increase availability of the Ministry of Health recom-
mended first-line anti-malarial treatment while decreas-
ing the use of SP and other anti-malarials for which
there is known drug resistance. Although AMFm has
expanded access to affordable ACT in the private sector
[10], drug retailers have been found to continue pre-
scribing outdated anti-malarials even with knowledge of
current recommended drugs. In two previous studies,
one conducted in rural Tanzania and the other in Kenya,
drug retailers who knew the recommended first-line
treatment for malaria were found to continue dispensing
and selling ineffective medications [11,12].
This study was conducted in November 2010 to survey
all private medicine retailers, including shops selling pri-
marily medicines and privately owned clinics, in the
Webuye Health and Demographic Surveillance Site
(WHDSS) in the Bungoma East District of western Kenya.
The study focused on evaluating medicine retailer know-
ledge of anti-malarials, specifically the first-line recom-
mended anti-malarial medication, as well as dispensing
and treatment practices. An additional goal of the study
was to discover if medicine retailers were aware of the
change in Ministry of Health guidelines regarding first-
line anti-malarial recommendations, and if this knowledge
had an impact on dispensing practices. The location of a
retail business, in an urban or rural setting, as well as the
type of retail business, as a shop or a private clinic, were
also examined to better understand the determinants of
medicine retailer knowledge and behaviour.
Methods
Study area and sample
The study was conducted in the Webuye Health and
Demographic Surveillance Site (WHDSS) in the Bungoma
East District of Kenya’s Western Province. Kenya has a
population of 39.8 million people according to the 2009
census, 78% of whom live in rural areas [13]. The Bun-
goma East District is located approximately 380 kilo-
meters west of Nairobi, the capital of Kenya. The WHDSS
is home to approximately 70,000 residents, and is
described in detail elsewhere [14]. The primary economy
is subsistence farming, with roughly 1,500 residents
employed by a local sugar-processing factory, and others
growing sugar cane to sell to the factory. There is a small
peri-urban centre just outside the DSS boundaries where
the district hospital is located. The malaria burden in the
WHDSS is particularly high, despite the varied transmis-
sion rates of the Western Province [15]. A study con-
ducted in 1998 in western Kenya found P. falciparum
parasites in 55.4% of asymptomatic children in the wet
season and 44% of children in the dry season [16].
The healthcare services within the WHDSS are pro-
vided by both the public and the private health sector.
The public sector is made up of four government-owned
health facilities: one district hospital, one health centre,
and two medicine dispensaries. In addition to these is
one faith-based hospital that offers healthcare services.
The private health sector is made up of many retail busi-
nesses, including privately owned pharmacies, drug out-
lets, traditional healers, and herbalists.
The study population included all drug-selling locations
that are privately owned, whether they self-identify as
pharmacies, chemists, specialized medicine retailers, or
private clinics, that are located within or are accessible to
those living in the WHDSS, up to or within 5 kilometers
of the WHDSS borders [10]. These locations were identi-
fied by a team of 10 fieldworkers each assigned a specific
region to cover on motorbike. Fieldworkers started in the
market centre and identified each outlet, taking down the
name and GPS coordinates of each. At each outlet, field-
workers asked outlet staff if there were any additional
outlets in the area. Fieldworkers continued visiting outlets
and inquiring after additional outlets until no new outlets
were identified. Inclusion criteria comprised of locations
selling anti-malarials, including privately owned clinics,
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medicine retail shops, chemists, privately owned pharma-
cies, and agrovets. Retail drug outlets were defined as
shops that are privately owned, and sell medication (spe-
cifically anti-malarials), and may or may not be licensed
to sell these medications. Agrovets were defined as a sub-
class of those drug outlets that sell medications for
human ailments, often including anti-malarials, as well as
products for veterinary use. Exclusion criteria included
public health facilities, general shops that sold mostly
consumables and only a few medications, and refusal to
participate in the survey.
Data collection
An interviewer-administered survey tool was used to col-
lect data on medicine retailer knowledge of the Ministry
of Health recommended first-line anti-malarial drug
treatment for uncomplicated malaria, self-reported
actions regarding diagnosis and dispensing practices, and
responses to scenarios involving customer interactions.
The scenarios included mothers inquiring after medica-
tion for a sick child with specific symptoms, or requesting
specific medication. Basic demographic data on medicine
retailers were included. Respondents’ health qualification
was categorized by type and by level. Responses of health
qualification types were pharmacy-trained, including phar-
macists, pharmacy technologists, and pharmacy assistants,
nurse or midwifery trained, including nurses, nursing
assistants, and midwives, and others, including clinical
officers and laboratory technicians. Responses of health
qualification level were professional-level training, includ-
ing pharmacists, nurses, and clinical officers, and
assistant-level training, including pharmacy assistants and
nursing assistants.
Details on the outlet location were also included in the
survey. Outlets located within Webuye Town were classi-
fied as urban locations, while locations outside of Webuye
Town were considered rural. Outlets were classified as
clinics if they self-identified as clinics by business name.
All others, such as pharmacies, chemists, and duka la
dawa (medicine shop) were classified as ‘shops’.
The survey included components from two previous
questionnaires used in retail outlet studies [17,18]. Field-
workers were trained on the survey tool, which was
piloted outside the study area. The fieldworkers visited
each location that had originally been identified during
the canvassing activity. They interviewed all the employ-
ees in each outlet who dispensed medicines to custo-
mers. All study participants provided verbal consent
before participating in the survey.
Data entry and analysis
Fieldworkers asked questions and recorded responses on
paper questionnaires. All collected data was double
entered into a Microsoft Access database and confirmed,
with discrepancies clarified by consulting the original
survey forms. Data was exported to and analyzed using
Stata v11. Unadjusted odds ratios were used to explore
factors related to anti-malarial drug knowledge and
practices. We considered p values of less than 0.05 to be
statistically significant. Adjusted odds ratios were used
when looking at the relationship between recommending
appropriate treatment in children and referral behaviour,
correcting for anti-malarial drug knowledge. Exact logis-
tic regression was used for comparisons with fewer than
nine observations in any category.
Ethical considerations
Ethical approval for the research was granted from ethical
review boards at Moi University Institutional Research
and Ethics Committee in Eldoret, Kenya and the Duke
University Institutional Review Board in Durham, North
Carolina. Additional approval was also sought from the
Webuye HDSS site authorities, community chiefs, assist-
ant chiefs, and village elders from the study area.
Results
The study community
There were 117 individuals from 97 different outlets that
participated in the survey. Of these, two individuals were
excluded from analysis on the basis that they did not dis-
pense medications and could not comment on anti-
malarial dispensing practices. Nearly all the outlets
included in the survey were in a rural setting (94%), and
were classified as shops (87%) rather than clinics (Table 1).
Characteristics of medicine retailers
Of the 115 respondents included in the analysis (Table 2),
71% were female, and 83% were under the age 40, with
Table 1 Characteristics of surveyed outlets
Variables N= 97 %
Type of retail outlet
Shop n= 84 87%
Clinic n = 13 13%
Location of retail outlet
Urban n= 6 6%
Rural n = 91 94%
Operating hours
< 8 hours per day n = 3 3%
8 - 10 hours per day n = 54 56%
> 10 hours per day n = 39 40%
Open on Saturday n = 82 85%
Open on Sunday n = 41 42%
Number of staff – Mean (min - max) 1.64 (1–6)
Number who dispense – Mean (min - max) 1.35 (1–3)
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the largest proportion of respondents (n = 52) between
the ages of 30 and 40. The majority of retailers surveyed
had reached an education level above secondary school
(67%), with fewer having just completed secondary
school (30%), and the smallest proportion having fin-
ished only primary school (2%, n = 2).
Over 83% of respondents had received health-related
training, with most of these having been trained in phar-
macy (40%) or in nursing/midwifery or as a clinical offi-
cer (42%). 18% of the survey respondents had no
relevant health training. These results are incongruous
with the self-reported education levels, since 82% of
those surveyed reported a health training in either phar-
macy, nursing/midwifery, or as a clinical officer but only
67% had received an education above secondary school.
Study findings showed a gender disparity in the health
training results. Male retailers were nearly three times
more likely than female retailers to have no related
health training (OR= 3.77, 95% CI 1.41 – 10.10;
p = 0.008). Men were also less likely to be trained in
nursing or midwifery than women (OR=0.22, 95% CI
0.08 – 0.59; p = 0.003).
Anti-malarial drug knowledge
In the survey, each respondent was asked an open-
ended question to identify which anti-malarial medica-
tion is recommended by the Ministry of Health to treat
uncomplicated malaria. Most of the population surveyed
correctly identified the first-line treatment (65%), but the
odds of knowing the recommended treatment were
higher amongst participants with health training (OR=
3.26, 95% CI 1.23 – 8.63; p = 0.017). Seventy-one percent
of those with health training correctly identified the
recommended anti-malarial medication, but less than
half the retailers without any health training identified
the recommended first-line anti-malarial (Table 3).
There was no difference in the percent of the nursing/
midwifery trained who identified AL as the first-line
therapy compared to those with pharmacy training, and
both were more likely to identify AL when compared to
retailers without training (OR= 3.28, 95% CI 1.12 – 9.65;
p = 0.031 pharmacy trained compared to the untrained;
OR= 3.24, 95% CI 1.12 – 9.39’ p = 0.031 nurse/midwifery
trained compared to the untrained).
Table 2 Background information on the surveyed
population, individual level variables, Western Province,
Kenya 2010
Variables N= 115 %
Age
Age 15-20 n = 1 1%
Age 20-30 n = 43 37%
Age 30-40 n = 52 45%
Age 40-50 n = 9 8%
Age 50-60 n = 6 5%
Age 60+ n= 2 2%
Female Ratio 71%
Health Qualification
Pharmacist n = 25 22%
Pharmacy Technologist n = 10 9%
Pharmacy Assistant n = 10 9%
Clinical Officer n = 1 1%
Nurse n = 38 33%
Nurse Assistant n = 9 8%
Laboratory Technician n = 1 1%
Other n = 6 5%
None n= 15 13%
Education
Completed primary n = 2 2%
Completed Secondary n = 35 30%
Some or completed above secondary n = 77 67%
Anti-malarial Training
Attended malaria workshop n= 46 40%
Attended malaria workshop after 2006 n= 34 30%
Received drug information from MOH n= 94 82%
Table 3 Association of medicine retailer characteristics
with correctly identifying the MOH recommended first-
line anti-malarial therapy




Under 30 44 77% (34) 1 (reference)
Between 30 and 40 52 52% (27) 0.32 (0.13 - 0.77; 0.012)*
Over 40 17 82% (14) 1.37 (0.33 - 5.75; 0.665)
Gender
Female 82 66% (54) 1 (reference)
Male 32 66% (21) 0.99 (0.42 - 2.34; 0.982)
Health qualification type
Untrained 21 43% (9) 1 (reference)
Pharmacy 45 71% (32) 3.28 (1.12 - 9.65; 0.031)*
Nurse/Midwife 48 71% (34) 3.24 (1.12 - 9.39; 0.031)*
Health qualification level
Untrained 21 43% (9) 1 (reference)
Assistant level 29 76% (22) 4.14 (1.25 - 14.09; 0.021)*
Professional level 64 69% (44) 2.93 (1.07 - 8.08; 0.037)*
Education level
Secondary or below 37 62% (23) 1 (reference)
Above secondary 77 68% (52) 1.27 (0.56 - 2.87; 0.572)
* denotes statistical significance.
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The level of health training, whether a retailer was
trained at an assistant level, such as a nursing assistant
or pharmacy assistant, rather than a professional, such
as a pharmacist, clinical officer, or nurse, was not a sig-
nificant predictor of identifying the MOH recommended
first-line anti-malarial. A slightly higher proportion of
assistants correctly identified the first-line anti-malarial,
at 76% (n = 22), compared to professionals, at 69%
(n = 44), although this comparison did not reach statis-
tical significance (OR= 1.43, 95% CI 0.525 – 3.89;
p = 0.485).
Assistants were less likely to have attended a workshop
on malaria treatment than professionals (OR= 0.27, 95%
CI 0.097 – 0.751; p = 0.012). However, those who attended
a workshop on malaria were not more likely to know the
correct first-line anti-malarial, even if that workshop was
after the change to AL as the first-line therapy in 2006
(Table 4a).
Level of education was not related to anti-malarial dug
knowledge. Sixty-two percent of those with a secondary
education or below identified AL as the MOH recom-
mended first-line therapy for malaria, and 68% of those
with above a secondary education identified the first-line
anti-malarial medication.
Anti-malarial dispensing practices
In the survey, each respondent was asked an open-ended
question to identify which anti-malarial medication they
would recommend to an adult or a pediatric client with
uncomplicated malaria. Retailers were not asked to specify
the dosages. In both cases, knowing the MOH recom-
mended anti-malarial medication was found to be a strong
predictor of recommending this medication (Table 4a).
Health-related qualification was also a significant
predictor of recommending the proper anti-malarial
treatment.
Table 4 a: Relationship between shop worker knowledge of Ministry of Health recommended first line anti-malarial
therapy and malaria training and dispensing practices
n % who correctly identified the
firstline anti-malarial therapy
Unadjusted odds ratio
(95% confidence interval; P value)
Malaria training
Attended malaria workshop
Yes 46 65% 0.94 (0.42 - 2.07; 0.873)
No 66 67% Ref
Attended malaria workshop after 2006
Yes 34 62% 0.32 (0.06 - 1.71; 0.184)
No 12 83% Ref
Received drug information from MOH
Yes 94 69% 0.96 (0.85 - 1.08; 0.483)
No 19 53% Ref
Dispensing Practices
Recommended AL for uncomplicated malaria in children under 5
Yes 43 74% 2.41 (1.01 - 5.76; 0.048)*
No 53 55% Ref
Recommend AL for uncomplicated malaria in adults
Yes 55 76% 3.55 (1.49 - 8.47; 0.004)*
No 42 48% Ref
Table 4b: Relationship between shop worker recommendation of AL to children under 5 and their response to clinical scenarios
n % who would recommend AL
to children under 5
Unadjusted odds ratio and
(95% confidence interval; P value)
Paediatric Case Management**
Refer pediatric patients rather than treat
Yes 43 49% 2.45 (1.04 - 5.79; 0.041)*
No 65 31% Ref
Refuse Fansidar to a mother requesting it
Yes 94 67% 3.59 (1.08 - 11.90; 0.036)*
No 19 58% Ref
* denotes statistical significance.
**self-reported responses to open-ended clinical scenario.
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Pharmacy-trained retailers had the highest proportion
of those who recommended AL as the first-line anti-
malarial treatment to adults when compared to un-
trained retailers (OR= 4.50, 95% CI 1.263 – 16.036;
0.020). However, training in nurse-midwifery was not a
statistically significant predictor of recommending AL to
adults (OR= 2.30, 95% CI 0.67 – 7.86; 0.184). For paedi-
atric clients, a higher proportion of those trained in
nursing or midwifery would recommend AL (44%) com-
pared to those trained in pharmacy (38%) and those
without training (24%), although these comparisons did
not reach statistical significance.
The level of health training was also associated with
recommending the appropriate first-line anti-malarial
drug, particularly in adults. Those with a professional
level of training were more than three times more likely
to recommend this treatment to adults when compared
to the untrained (OR= 3.89, 95% CI 1.16 – 13.03;
p = 0.027). There was a general trend of increasing pro-
portion of respondents correctly recommending AL to
both adults and children as the level of training
increased, except that assistants seemed to have a
slightly higher proportion recommending AL to chil-
dren than professionals. However, this did not reach
statistical significance.
Recommending the current first-line anti-malarial to
either adult or pediatric clients was not associated with
having attended a workshop on malaria or anti-malarial
drugs (Table 4), regardless of whether the workshop was
held before or after the change to AL in 2006. The same
is true for medicine retailers having received information
on anti-malarial drugs from the Ministry of Health.
Retailer actions and behaviours
Study participants were asked to respond to a scenario
in which a mother requests Fansidar tablets, an outdated
anti-malarial medication containing sulphadoxine and
pyrimethamine (SP), for a sick child. How a participant
would react in this situation was recorded as an open-
ended response. Thirty-five percent of respondents said
they would give the mother different medicine, though
these responses did not determine whether that medi-
cine would be an anti-malarial or not. Twenty-five per-
cent of respondents would refer the mother and child to
a heath facility or laboratory for testing, 17% would dis-
pense Fansidar to the mother, 14% would request more
history, and 4.5% each would either give the mother a
non-malaria drug or would tell her they do not have
Fansidar.
The responses to the scenario formed two groups –
those who would dispense SP that the mother requested,
and those who would refer the child or ask for more in-
formation about the child’s condition. It was found that
retailers in the latter group were 2.5 times more likely to
have reported AL as the treatment they would recom-
mend to children with uncomplicated malaria (OR=
2.45, 95% CI 1.04 – 5.80; 0.041) (Table 4). Even when
controlling for whether a retailer knew or did not know
the MOH-recommended first-line anti-malarial, referral
practice remains correlated with recommending ap-
propriate treatment for children (Adjusted OR=2.50,
95% CI 1.04 – 6.02; 0.041).
Choosing to refer rather than dispense SP was asso-
ciated with knowing the appropriate first-line anti-
malarial medication, but there was still a high percentage
of retailers who knew the MOH recommended anti-
malarial and would dispense SP to a mother who requests
it. Of those who would give SP in this scenario, 58% of
them had previously reported AL as the MOH recom-
mended first-line anti-malarial treatment.
Whether a retailer works in a shop or a clinic is asso-
ciated with dispensing SP to mothers who request it.
Sixty-three percent of those working in shops would
withhold SP, while 19% would dispense it to their cus-
tomer. Of those working in a clinic, 92% would withhold
SP in favor of further examining the patient, or referring
to a laboratory or health facility, and none would dis-
pense SP to their customer.
Retailer motivations behind choosing which anti-
malarials to stock and which to dispense were also cor-
related with recommending the first-line anti-malarial to
children. Participants were asked an open-ended ques-
tion regarding how they decide what malaria medica-
tions to carry in their outlets. Those who said they stock
according to the anti-malarials recommended by the
Ministry of Health (n = 24) were 6 times more likely to
correctly identify the MOH-recommended anti-malarial
for children under 5 than those who stock according
to what their customers demand (n = 74; OR= 6.00,
95% CI 1.90 – 18.99; 0.002). However, the motivations
behind drug stocking were not correlated to recom-
mending the appropriate treatment in adults.
Participants were also asked an open-ended question
regarding how they choose which anti-malarial to dis-
pense to a customer when they have more than one
anti-malarial available. Those who would dispense
according to MOH guidelines (n = 11) were seven times
more likely to recommend the appropriate first-line
treatment to children than those who dispense according
to customer demands (n = 41; OR= 7.00, 95% CI 1.24 –
39.49; 0.027). Dispensing practice was not correlated
with whether they recommend correctly for adults.
To understand if customer pressure could explain this
gap between anti-malarial knowledge and dispensing
practices, additional analyses were conducted on the re-
lationship between medicine retailers and their custo-
mers. However, it was found that 98% of all retailers
surveyed said they provide advice outside the customers’
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demands, 95% suggest specific medicines to their custo-
mers, and 89% said their customers would take this ad-
vice and purchase the medication they recommend.
Very few retailers were found to act solely on customer
demand. It was, therefore, difficult to isolate the effect of
customer demand on dispensing practices.
Discussion
Retail medicine outlets are an important source of
treatment for febrile illness, including dispensing anti-
malarials. Self-medication with drugs purchased at retail
outlets is a common practice [6-9,19], and medicine
retailers have an important role in the diagnosis and
treatment of their customers [20]. It is important to
understand the determinants of medicine retailer dispens-
ing and treatment practices if malaria case management is
to be improved.
This study explored drug retailer characteristics, level
of training, level of education, anti-malarial drug know-
ledge, and dispensing practices in rural western Kenya.
In this study population there was a high proportion of
medicine retailers who reported having an education at
or below secondary school, 33%. This finding is in align-
ment with evidence from previous studies that also
found education levels to vary across retailers [21,22].
However, where these studies found the proportion of
participants with health-related training to be between
20 and 26%, over 80% of the participants in this study
reported health-related training.
In concurrence with previous studies on medicine re-
tailer anti-malarial drug knowledge [5,11], this study
found that most retailers were aware of the current
recommended treatment for uncomplicated malaria.
Sixty-five percent of participants in the study population
identified the Kenya Ministry of Health recommended
first-line anti-malarial. Additionally, participants who
correctly identified the current treatment for malaria
recommended by the MOH were found to be more
likely to recommend that treatment to both adult and
pediatric clients. This suggests that the change in the
recommended anti-malarial treatment from SP to AL
made in 2006 by the MOH has had an impact on retailer
anti-malarial knowledge as well as dispensing practices.
This study also found that a medicine retailer’s training
is a significant determinant of their reported anti-
malarial drug knowledge. Having a health-related qualifi-
cation was a significant predictor of identifying the
current first-line treatment for malaria when compared
to having no qualification, or qualification in a field unre-
lated to health, indicating that it is not professional train-
ing alone that improves anti-malarial drug knowledge,
but pertinent and relevant training. The type of health
training, be that in the field of pharmacy or of nursing,
was not found to be a determinant of identifying the
recommended first-line anti-malarial medication. How-
ever, pharmacy-trained retailers were more likely to rec-
ommend appropriate treatment for adults, and nurse or
midwifery-trained retailers were more likely to recom-
mend the appropriate treatment for children. This could
be a result of the curriculum behind these types of train-
ings, or the previous work experience common to each
field. Both pharmacy and nursing/midwifery-trained
retailers were significantly more likely to have appropri-
ate knowledge and dispensing practices than the un-
trained, further underscoring the need for medicine
retailers to have at least a basic training in a health-
related field.
Even though retailer training is an important factor
in knowing the current recommended first-line anti-
malarial treatment, and this knowledge increases the
likelihood of a retailer dispensing medication appropri-
ately, there remained disappointingly low proportions of
staff who would recommend appropriate treatment. Of
those who identified the current first-line anti-malarial,
only 56% would recommend AL to adults, and only 43%
would recommend it to children. This finding is in keep-
ing with evidence reported in previous studies that
found the proportion of appropriate retailer behaviour
to be low considering its importance for effective mal-
aria control [5,20,21,23] and that retailers often dispense
inappropriately despite having accurate treatment know-
ledge. This suggests that there are determinants to re-
tailer behaviour, as it specifically relates to dispensing
practices, which are stronger than the influence of re-
tailer knowledge.
In examining treatment practices through the use of
scenarios, 17% percent of respondents would dispense
an ineffective medicine, SP, to a mother who specifically
requested that medicine. Of these retailers, 58% of them
had identified AL as the MOH recommended first-line
treatment for malaria. Participants who refer a sick child
rather than dispense at the mother’s request are more
likely to recommend the appropriate anti-malarial medi-
cations to children than those who would treat the child
and not refer.
Customer demand is potentially a strong driving force
for dispensing practices. Thirty-five percent of partici-
pants said that they would dispense malaria medicine
according to what customers demanded, the most fre-
quently cited reason for choosing which medication to
dispense. This finding is consistent with that of Okeke
and colleagues in their study on treatment practices of
drug vendors in southeast Nigeria [8]. They found that
61.5% of those surveyed would dispense medications
according to what customers demanded. Participants in
their study would dispense anti-malarial drugs according
to what their customer requested, or could afford, even
if this action was contrary to what they knew to be
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appropriate treatment for malaria. Given that the majority
of retailers reported providing advice outside of customer
demand, but that customer demand is a significant factor
in stocking and dispensing practices, future research from
both the customer and retailer perspectives would be use-
ful in understanding this dynamic.
This finding is consistent with study findings regarding
stocking and dispensing practices to be related to anti-
malarial knowledge. Retailers who reported stocking and
dispensing drugs based on Ministry of Health guidelines
are more likely to identify the recommended malaria
treatment than retailers who dispense according to the
demands of their customers. Retailers who reported
stocking their drugs according to MOH guidelines are
more likely to know the current first-line anti-malarial
than retailers who stock according to customer demand.
This is further evidence that Ministry of Health guidelines
have an impact on medicine retailer treatment and dis-
pensing practices, but even though knowing the MOH
guidelines influences stocking and dispensing practices,
still too few retailers adhere to these recommendations.
There was an inconsistency between participants’ self-
reported health training and education levels, since 82%
of the study participants reported having health training
in pharmacy or nursing/midwifery, but only 67% of the
population reported an education level above secondary
school. These results could be explained by either the
participants misunderstanding the health training survey
question, or that they self-identify with a certain health
title that comes from holding that occupation rather
than from having formal training. A similar dichotomy
was discovered in a recent qualitative investigation that
studied a similar population in the same area [20]. It was
the opinion of the local research team that medicine
retailers, particularly in the rural areas, are referred to
by the local community as “pharmacists” or “nurses” be-
cause these are the roles they fill in the community, even
if those individuals do not hold official health qualifica-
tions in that field. It was conjectured that these retailers
may self-identify in accordance with these roles. If some
participants who self-identified as nurses or pharmacists
actually lacked formal training, this could explain why
relatively low proportions of trained personnel knew and
recommended the first-line therapy. If this is the case, it
would be expected that the association between training
and knowledge of effective anti-malarials would be
stronger than was observed.
A strong gender divide was also revealed in this study,
indicating that male and female retailers are consistently
dissimilar in whether they have health training and the
type of health training they have, and that these factors
may influence the additional differences in patient treat-
ment practices. The men surveyed in this study were
nearly four times more likely than women to be untrained
and are less likely to be trained in nursing or midwifery, a
health field associated with higher proportions of appro-
priately recommending treatment in children.
All data were self-reported actions, not directly observed
behaviours, and are, therefore, subject to reporting bias.
Particularly in reference to training, it is possible that
many respondents over-reported their qualifications. The
interviewer did not directly observe training credentials
and licenses. The study was also conducted over one geo-
graphic area, which may limit generalizability of study
findings.
Conclusions and recommendations
Malaria remains a major challenge to the health and
well-being of the people of Kenya, and is still the nation’s
fifth leading cause of death of both children and adults
[3]. The appropriate use of anti-malarials and the fast
and accurate treatment of malaria cases are both critical
to malaria control [24]. Retail drug outlets are often the
first point of care sought by patients, particularly for chil-
dren with febrile episodes [9]. Drugs purchased at retail
outlets are often used to self-treat [6-9,19] and drug
retailers have been found to have a role in the diagnosis
of their customers as well as the selection of medications
purchased [20].
The relationship retailers have with their customers
positions them well to increase the rate of appropriate
treatment for malaria and improve malaria case manage-
ment. It is then of utmost importance to target training
and education interventions in retail drug outlets and to
inform such interventions with the evidence found in
medicine retailer behaviour and practice studies. The
findings of this study are confirmation to most previous
studies. Most retailers are aware of the recommended
first-line treatment for malaria, but the percentages that
are not aware is far too high, and reported adherence to
that knowledge is far too low. While it is encouraging to
see evidence that Ministry of Health guidelines for appro-
priate anti-malarials are well known amongst retailers, it
is important to recognize that significant improvements to
retailer knowledge and behaviour need to be realized be-
fore malaria control can be improved in this area. Medi-
cine retailer treatment and dispensing practices are a vital
part of appropriate management of malaria. Knowing the
right anti-malarial medication is an important first step,
but adhering to that knowledge influences patient out-
comes directly.
Well-designed interventions should focus on the large
population of untrained retailers, as their outcomes in
terms of knowledge and dispensing practices are poorest.
It is important for medicine retailers to have health-
related training, that their training is current, and that
they be given specific information regarding the appro-
priate treatment of malaria in children. Interventions
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should also have educational components focused on pa-
tient management, including referral practice for patients
under five years of age. Previous studies have documen-
ted the success of education efforts at the retail provider
level. Marsh and colleagues [25] found that educating re-
tail drug outlet workers in rural Kenya increased the fre-
quency and accuracy of anti-malarial drug advice given
to customers, had a positive effect on customer adher-
ence to recommended dosages, and improved anti-
malarial drug access to children.
There is an opportunity for future interventions to le-
verage the influence customer demand has on retailer
behaviour by focusing education efforts on patient com-
munities. Specifically targeting mothers may additionally
improve outcomes for children, and help increase aware-
ness of AL as the first-line treatment for malaria in both
children and adults.
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